Get started
Author

Nithisha Khasnavis

Observed names: N. Khasnavis, Nithisha S. Khasnavis
ORCID: 0000-0002-2956-709X
Observed ORCID: 0000-0002-2956-709X
OpenAlex ID: A5043843338
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations
2020 · Talayeh S. Ghezelayagh, Kathryn P. Pennington, et al. · Gynecologic Oncology · 38
Detecting Reconnaissance and Discovery Tactics from the MITRE ATT&CK Framework in Zeek Conn Logs Using Spark’s Machine Learning in the Big Data Framework
2022 · Sikha Bagui, Dustin Mink, et al. · Sensors · 23
PDF
Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas
2021 · Sahana Somasegar, Arielle S. Weiss, et al. · Gynecologic Oncology · 19
KiRNet: Kinase-centered network propagation of pharmacological screen results
2021 · Thomas Bello, Marina Chan, et al. · Cell Reports Methods · 16
Diagnosis of Ovarian Carcinoma Homologous Recombination DNA Repair Deficiency From Targeted Gene Capture Oncology Assays
2023 · Niklas Krumm, Nithisha S. Khasnavis, et al. · JCO Precision Oncology · 6
PDF
Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years
2020 · Arielle S. Weiss, Elizabeth Swisher, et al. · Gynecologic Oncology · 6
LBA34 Association of homologous recombination deficiency (HRD) with clinical outcomes in a phase III study of olaparib or cediranib and olaparib compared to platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer (PSOC): Biomarker analyses from NRG-GY004
2021 · E. Swisher, A. Miller, et al. · Annals of Oncology · 5
Germline mutations in Black women with ovarian, fallopian tube and primary peritoneal carcinomas
2021 · Sahana Somasegar, Arielle Weiss, et al. · Gynecologic Oncology · 1
Abstract 3541: Dynamics of clonal hematopoiesis in ovarian cancer survivors: Correlation with carboplatin and PARP inhibitor exposure
2026 · Elizabeth M. Swisher, Marc R. Radke, et al. · Cancer Research
Abstract IA023: Clonal hematopoiesis and risk of therapy-related myeloid neoplasms in tubo-ovarian cancer survivors
2025 · Elizabeth M. Swisher, Marc R. Radke, et al. · Cancer Research
Abstract A044: Application of HRDefine: a biomarker for identifying root causes of homologous recombination deficiency to a phase 3, randomized, placebo-controlled trial of veliparib in front-line treatment of advanced ovarian cancer (VELIA/GOG-3005)
2025 · Isabel V. Rodriguez, Marc Radke, et al. · Cancer Research
Abstract 3615: Clonal hematopoiesis in ovarian cancer survivors: Correlation with carboplatin and PARP inhibitor exposure
2025 · Marc R. Radke, Nithisha Khasnavis, et al. · Cancer Research
KiRNet: Integrated, Kinase-Centered Network Modeling Predicts Mechanisms Behind Phenotypic Associations
2020 · Thomas Bello, Marina Chan, et al. · SSRN Electronic Journal
Works count: 13
Citation count: 114
H-index: 6
I10-index: 4
Year
Topic
Type